hero section gradient
10 handpicked stocks

Go Global

As investors seek alternatives to US assets, these international markets are gaining attention. Our analysts have carefully selected these ETFs to help you capitalize on global opportunities and diversify beyond US borders.

Author avatar

Han Tan | Market Analyst

Published on May 8

Your Basket's Financial Footprint

Interpretation of provided market capitalisation data for the 'Go Global' basket: total market cap $.000 with no constituent breakdown.

Key Takeaways for Investors:
  • Large-cap dominance generally means lower volatility and closer market tracking; here such dominance isn't verifiable.
  • Treat as a potential core holding if large-cap exposure is confirmed; otherwise clarify constituents first.
  • Expect steady, long-term appreciation rather than explosive short-term gains, if large-cap anchoring is present.
Total Market Cap

About This Group of Stocks

1

Our Expert Thinking

With Trump's "America First" policies reshaping markets, smart investors are looking beyond US borders. These international ETFs provide exposure to economies that are becoming less dependent on the US, potentially benefiting from increased domestic spending in places like Germany and China.

2

What You Need to Know

This collection offers true geographic diversification across Europe and Asia. These markets may provide a buffer against US-specific volatility while giving you access to different currencies, economic cycles, and growth stories that complement a US-focused portfolio.

3

Why These Stocks

These ETFs were strategically chosen to capture value in international markets that have lagged behind US stocks in recent years. They represent regions where large institutional investors are already reallocating funds, potentially creating momentum for growth.

Why You'll Want to Watch These Stocks

🌍

Global Wealth Shift Happening Now

Large institutions are already moving money into international markets. These ETFs let you follow this capital flow and potentially benefit from the global reallocation trend.

💰

Undervalued Opportunities Abroad

Many of these international markets offer more attractive valuations than US stocks right now. You could be getting quality exposure at better price points with greater growth potential.

🛡️

Protection Against US Market Turbulence

As Trump's policies create uncertainty in American markets, these global investments can help shield your portfolio from domestic volatility while keeping your money working for you.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Airbus has cut its delivery targets after discovering a significant fuselage flaw in its A320 aircraft, causing production delays and requiring widespread inspections. This situation could create a significant opening for its main competitor, Boeing, and other aerospace manufacturers to capture market share from airlines seeking to avoid delivery uncertainties.

Cargo Capacity Crisis: Which Stocks May Benefit Most?

Cargo Capacity Crisis: Which Stocks May Benefit Most?

The crash of a UPS cargo plane has led to the grounding of an entire class of aging aircraft across the logistics industry. This creates a potential investment opportunity in competing cargo carriers and aircraft manufacturers poised to fill the resulting gap in shipping capacity.

UK-US Pharma Trade Deal | Tariff-Free Market Access

UK-US Pharma Trade Deal | Tariff-Free Market Access

A new trade deal eliminates tariffs on pharmaceuticals between the UK and the US, strengthening transatlantic trade. This creates a powerful tailwind for pharmaceutical companies in both countries, potentially boosting exports, innovation, and profitability.

Frequently Asked Questions